🇺🇸 FDA
Patent

US 11040970

VMAT2 inhibitor compounds and compositions thereof

granted A61PA61P25/00

Quick answer

US patent 11040970 (VMAT2 inhibitor compounds and compositions thereof) held by Neurocrine Biosciences, Inc. expires Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Neurocrine Biosciences, Inc.
Grant date
Tue Jun 22 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
29
CPC classes
A61P, A61P25/00